Home › Research › Brain scans and imaging
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ.. Neurology, 2010-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To investigate the specificity of in vivo amyloid imaging with [(11)C]-Pittsburgh Compound B (PIB) in Parkinson disease dementia (PDD). Methods We performed detailed neuropathologic examination for 3 individuals with PDD who had PIB PET imaging within 15 months of death. Results We observed elevated cortical uptake of [(11)C]-PIB on in vivo PET imaging in 2 of the 3 cases. At autopsy, all 3 individuals had abundant cortical Lewy bodies (Braak PD stage 6), and were classified as low-probability Alzheimer disease (AD) based on NIA-Reagan criteria. The 2 PIB-positive individuals had abundant diffuse Abeta plaques but only sparse neuritic plaques and intermediate neurofibrillary tangle pathology. The PIB-negative individual had rare diffuse plaques, no neuritic plaques, and low neurofibrillary tangle burden. Conclusions [(11)C]-Pittsburgh Compound B (PIB) PET is specific for fibrillar Abeta molecular pathology but not for pathologic diagnosis of comorbid Alzheimer disease in individuals with Parkinson disease dementia. The ability to specifically identify fibrillar Abeta amyloid in the setting of alpha-synucleinopathy makes [(11)C]-PIB PET a valuable tool for prospectively evaluating how the presence of Abeta amyloid influences the clinical course of dementia in patients with Lewy body disorders.
What this study adds
Evidence grade: Low
In three people with Parkinson disease dementia scanned within 15 months of death, amyloid PET (PIB) was elevated in two. At autopsy those two had abundant diffuse amyloid plaques but only sparse neuritic plaques, and all three met only "low-probability" Alzheimer criteria.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Burack, M. A., Hartlein, J., Flores, H. P., Taylor-Reinwald, L., Perlmutter, J. S., & Cairns, N. J. (2010). In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology. https://doi.org/10.1212/wnl.0b013e3181c7da8e
Vancouver
Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology. 2010. doi:10.1212/wnl.0b013e3181c7da8e. PMID: 20038776.
BibTeX
@article{burack2010-20038776,
author = {Burack, M. A. and Hartlein, J. and Flores, H. P. and Taylor-Reinwald, L. and Perlmutter, J. S. and Cairns, N. J.},
title = {{In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia}},
journal = {Neurology},
year = {2010},
doi = {10.1212/wnl.0b013e3181c7da8e},
pmid = {20038776},
url = {https://doi.org/10.1212/wnl.0b013e3181c7da8e}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results We observed elevated cortical uptake of [(11)C]-PIB on in vivo PET imaging in 2 of the 3 cases.
Why it matters
In three people with Parkinson disease dementia scanned within 15 months of death, amyloid PET (PIB) was elevated in two. At autopsy those two had abundant diffuse amyloid plaques but only sparse neuritic plaques, and all three met only "low-probability" Alzheimer criteria. The authors conclude that PIB PET is "specific for fibrillar Abeta molecular pathology but not for pathologic diagnosis of comorbid Alzheimer disease" in this group, which is a caution against reading a positive scan as an Alzheimer's diagnosis. This comes from three cases only.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 49/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2010 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 165 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.2 citations a year over 18 year(s) since 2010 |
| Impact for its field and year | 4 / 6 | Cited 11.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 19 other studies in this library |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Nigel J. Cairns: h-index 101 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Rochester: institution h-index 1,195 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 20038776) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 23.
Later studies that cite this one
19 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Brain scans and imaging from nearby years
Also tagged “machine”
834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.